Related references
Note: Only part of the references are listed.Overexpression of HIF-1α contributes to melphalan resistance in multiple myeloma cells by activation of ERK1/2, Akt, and NF-κB
Masanobu Tsubaki et al.
LABORATORY INVESTIGATION (2019)
Regulation of RhoA GTPase and various transcription factors in the RhoA pathway
Jae-Gyu Kim et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Tamoxifen suppresses paclitaxel-, vincristine-, and bortezomib-induced neuropathy via inhibition of the protein kinase C/extracellular signal-regulated kinase pathway
Masanobu Tsubaki et al.
TUMOR BIOLOGY (2018)
Pharmacological Inhibition of Myocardin-related Transcription Factor Pathway Blocks Lung Metastases of RhoC-Overexpressing Melanoma
Andrew J. Haak et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Associations of Statins and Diabetes with Diagnosis of Ulcerated Cutaneous Melanoma
Lena A. von Schuckmann et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Nivolumab and pembrolizumab: Monoclonal antibodies against programmed cell death-1 (PD-1) that are interchangeable
Vinay Prasad et al.
SEMINARS IN ONCOLOGY (2017)
Statins induce apoptosis through inhibition of Ras signaling pathways and enhancement of Bim and p27 expression in human hematopoietic tumor cells
Daichiro Fujiwara et al.
TUMOR BIOLOGY (2017)
Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth
Juan Li et al.
CELL DEATH & DISEASE (2017)
Management of intracranial melanomas in the era of precision medicine
Grace J. Young et al.
ONCOTARGET (2017)
Specific role of RhoC in tumor invasion and metastasis
Sarah Lang et al.
ONCOTARGET (2017)
Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma
Yang Cheng et al.
ONCOTARGET (2017)
Overcoming resistance to targeted therapy with immunotherapy and combination therapy for metastatic melanoma
Hilary R. Keller et al.
ONCOTARGET (2017)
Contributions of MET activation to BCR-ABL1 tyrosine kinase inhibitor resistance in chronic myeloid leukemia cells
Masanobu Tsubaki et al.
ONCOTARGET (2017)
The sensitivity of head and neck carcinoma cells to statins is related to the expression of their Ras expression status, and statin-induced apoptosis is mediated via suppression of the Ras/ERK and Ras/mTOR pathways
Masanobu Tsubaki et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2017)
Mangiferin, a novel nuclear factor kappa B-inducing kinase inhibitor, suppresses metastasis and tumor growth in a mouse metastatic melanoma model
Tomoya Takeda et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2016)
Annexin-A1 controls an ERK-RhoA-NFκB activation loop in breast cancer cells
Pradeep Bist et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a
Adam R. Wolfe et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Rho Kinase Inhibitors Block Melanoma Cell Migration and Inhibit Metastasis
Amine Sadok et al.
CANCER RESEARCH (2015)
HOXD10 acts as a tumor-suppressive factor via inhibition of the RHOC/AKT/MAPK pathway in human cholangiocellular carcinoma
Haixia Yang et al.
ONCOLOGY REPORTS (2015)
PKC/MEK inhibitors suppress oxaliplatin- induced neuropathy and potentiate the antitumor effects
Masanobu Tsubaki et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
Suzanne L. Topalian et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Wogonin Suppresses Melanoma Cell B16-F10 Invasion and Migration by Inhibiting Ras-Medicated Pathways
Kai Zhao et al.
PLOS ONE (2014)
ARHGAP21 is a RhoGAP for RhoA and RhoC with a role in proliferation and migration of prostate adenocarcinoma cells
Mariana Lazarini et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
The role of RhoC in ovarian epithelial carcinoma: A marker for carcinogenesis, progression, prognosis, and target therapy
Yang Zhao et al.
GYNECOLOGIC ONCOLOGY (2013)
Effect of estrogen and tamoxifen on the expression pattern of AP-1 factors in MCF-7 cells: role of c-Jun, c-Fos, and Fra-1 in cell cycle regulation
R. L. Babu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)
Safety and Tumor Responses with Lambrolizumab (Anti-PD-1) in Melanoma
Omid Hamid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis
Raul Aguirre-Gamboa et al.
PLOS ONE (2013)
Serum response factor is overexpressed in esophageal squamous cell carcinoma and promotes Eca-109 cell proliferation and invasion
Xi He et al.
ONCOLOGY LETTERS (2013)
Efficacy and Mechanism of Angiotensin II Receptor Blocker Treatment in Experimental Abdominal Aortic Aneurysms
Yasunori Iida et al.
PLOS ONE (2012)
Acquired and intrinsic BRAF inhibitor resistance in BRAF V600E mutant melanoma
Inna V. Fedorenko et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Long-term Use of Cholesterol-Lowering Drugs and Cancer Incidence in a Large United States Cohort
Eric J. Jacobs et al.
CANCER RESEARCH (2011)
A p27kip1-binding Protein, p27RF-Rho, Promotes Cancer Metastasis via Activation of RhoA and RhoC
Daisuke Hoshino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Statin-induced apoptosis via the suppression of ERK1/2 and Akt activation by inhibition of the geranylgeranyl-pyrophosphate biosynthesis in glioblastoma
Masashi Yanae et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
Nitrogen-containing bisphosphonate, YM529/ONO-5920, inhibits tumor metastasis in mouse melanoma through suppression of the Rho/ROCK pathway
Yoshihiro Tanimori et al.
CLINICAL & EXPERIMENTAL METASTASIS (2010)
Hyaluronan-CD44 Interaction Promotes c-Src-mediated Twist Signaling, MicroRNA-10b Expression, and RhoA/RhoC Up-regulation, Leading to Rho-kinase-associated Cytoskeleton Activation and Breast Tumor Cell Invasion
Lilly Y. W. Bourguignon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Reduction of lung metastasis, cell invasion, and adhesion in mouse melanoma by statin-induced blockade of the Rho/Rho-associated coiled-coil-containing protein kinase pathway
Yasuhiro Kidera et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Pretreatment with Statin Attenuates the Cardiotoxicity of Doxorubicin in Mice
Alexander Riad et al.
CANCER RESEARCH (2009)
Dimethylfumarate inhibits tumor cell invasion and metastasis by suppressing the expression and activities of matrix metalloproteinases in melanoma cells
Yuzuru Yamazoe et al.
CELL BIOLOGY INTERNATIONAL (2009)
Tamoxifen inhibits tumor cell invasion and metastasis in mouse melanoma through suppression of PKC/MEK/ERK and PKC/PI3K/Akt pathways
Hiroshi Matsuoka et al.
EXPERIMENTAL CELL RESEARCH (2009)
Loss of Cell-Cell Contacts Induces NF-κB Via RhoA-Mediated Activation of Protein Kinase D1
Catherine F. Cowell et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis
Souhila Medjkane et al.
NATURE CELL BIOLOGY (2009)
PRL-3 facilitates angiogenesis and metastasis by increasing ERK phosphorylation and up-regulating the levels and activities of Rho-A/C in lung cancer
Jian Ming et al.
PATHOLOGY (2009)
Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival
Dusan Bogunovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The safety of statins in clinical practice
Jane Armitage
LANCET (2007)
Is station use associated with a reduced incidence, a reduced Breslow thickness or delayed metastasis of melanoma of the skin?
E. R. Koomen et al.
EUROPEAN JOURNAL OF CANCER (2007)
The protein kinase C inhibitor, H7, inhibits tumor cell invasion and metastasis in mouse melanoma via suppression of ERK1/2
Masanobu Tsubaki et al.
CLINICAL & EXPERIMENTAL METASTASIS (2007)
Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: Drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions
Yoshihisa Shitara et al.
PHARMACOLOGY & THERAPEUTICS (2006)
AP-1 regulates α2β1 integrin expression by ERK-dependent signals during megakaryocytic differentiation of K562 cells
M Eriksson et al.
EXPERIMENTAL CELL RESEARCH (2005)
Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo
JY Pillé et al.
MOLECULAR THERAPY (2005)
Mevastatin induces apoptosis in HL60 cells dependently on decrease in phosphorylated ERK
S Nishida et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2005)
Simvastatin does not have a clinically significant pharmacokinetic interaction with fenofibrate in humans
AJ Bergman et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Share Paper
